课题基金 / 基金详情

Nitroxides as Protectors Against Oxidative Stress

Nitroxides as Protectors Against Oxidative Stress
氮氧化物作为氧化应激的保护剂
批准号:
10262693
负责人:
James Mitchell
金额:
$27.78万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

James Mitchell的其他基金

相似基金

相关文献

中文摘要
翻译
氮氧化物(铅化合物,Tempol)是一种有效的抗氧化剂,被证明在许多疾病过程和/或表现过度氧化应激的条件下具有广泛的用途。氮氧化物在如此广泛的疾病条件下发挥活性的事实说明了组织中自由基反应的重要性。同样,自由基在正常分子信号通路和相关基因表达中的重要作用也越来越明显。我们发表了一项研究,表明Tempol应用可以保护暴露在辐射中的正常组织。采用小型猪(minipig)口腔黏膜炎模型,动物每天暴露于5 x 6 Gy的分次辐射中,在每次辐射分次前10分钟给予氮氧化物Tempol。Tempol可以防止辐射引起的粘膜炎和溃疡。这些发现与最近进行的小鼠研究一致,显示出类似的辐射防护效果。我们相信Tempol值得在临床试验中进行评估,以防止辐射引起的粘膜炎。我们已经发表了评估Tempol降低多发性硬化症(MS)严重程度和进展的研究。几种活性氧(ROS)和活性氮(RNS)与MS及其动物模型实验性自身免疫性脑脊髓炎(EAE)中炎症介导的中枢神经系统(CNS)损伤有关。本研究的目的是探讨口服天宝对EAE小鼠模型的免疫调节作用和治疗潜力。与对照组动物相比,在诱导活性EAE前2周随意接受Tempol食物的小鼠表现出发病延迟和发病率降低。疾病严重程度降低与小胶质细胞激活受限和炎症浸润减少有关。Tempol的作用是免疫调节,而不是免疫抑制:T细胞产生较少的干扰素γ和肿瘤坏死因子α。Tempol给药与CD8+ T细胞群和CD4+FoxP3+调节细胞群的富集有关。Tempol治疗在疾病诱发后和临床症状出现后也可降低疾病的严重程度。口服Tempol减少炎症和轴突损伤和损失的能力显示出抗炎和保护特性,为治疗多发性硬化症和相关神经系统疾病带来了重大希望。
英文摘要
Nitroxides (lead compound, Tempol), which are potent antioxidants, are proving to have broad utility in a number of disease processes and/or conditions that represent excessive oxidative stress. The fact that nitroxides exert activity over such a range of disease conditions speaks to the importance of free radical reactions in tissue. Likewise, it is becoming apparent that free radicals are important in normal molecular signaling pathways and related gene expression. We have published a study that shows Tempol application can provide protection of normal tissues exposed to radiation. Using a miniature pig (minipig) model for irradiation-induced oral mucositis, animals were exposed to daily fractionated radiation (5 x 6 Gy), where the nitroxide Tempol was administered i.p. 10 min before each radiation fraction. Tempol provided protection against radiation-induced mucositis and ulceration. These findings are consistent with mouse studies conducted recently showing comparable radioprotective effects. We believe Tempol is worthy of being evaluated in clinical trials to protect against radiation-induced mucositis. We have published studies evaluating Tempol to reduce the severity and progression of multiple sclerosis (MS). Several reactive oxygen (ROS) and reactive nitrogen species (RNS) are implicated in inflammatory-mediated damage to the central nervous system (CNS) in MS and its animal model, experimental autoimmune encephalomyelitis (EAE). The goal of these studies was to investigate the immunomodulatory effects and therapeutic potential of orally-delivered Tempol in the mouse EAE model. Mice receiving Tempol chow ad libitum for 2 weeks prior to induction of active EAE showed delayed onset and reduced incidence of disease compared to control-fed animals. Reduced disease severity was associated with limited microglial activation and fewer inflammatory infiltrates. Tempol's effects were immunomodulatory, not immunosuppressive: T cells produced less interferon-gamma and tumor necrosis factor-alpha. Tempol administration was associated with an enrichment of CD8+ T cell populations and CD4+FoxP3+ regulatory populations. Tempol treatment also reduced the severity of disease when administered after the induction of disease, and also after the onset of clinical symptoms. The ability of oral Tempol to reduce inflammation and axonal damage and loss demonstrate both anti-inflammatory and protective properties, holds significant promise for the treatment of MS and related neurological disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nitroxides as Protectors Against Oxidative Stress
Modulation of Therapeutic Response
Modulation of Therapeutic Response
Protection against Radiation-Induced Carcinogenesis
  • 批准号:
    8349242
  • 项目类别:
  • 资助金额:
    $32.13万
  • 财政年份:
    --
  • 负责人:
    James Mitchell
  • 依托单位:
海外基金